跳至主要内容
临床试验/NCT07053579
NCT07053579已完成不适用

Cross-cultural Adaptation and Validation of the Pediatric Chemotherapy-induced Neuropathy (P-CIN) for Chinese Pediatric Oncology Patients: A Multi-center Study

The Hong Kong Polytechnic University2 个研究点 分布在 1 个国家目标入组 313 人开始时间: 2025年1月5日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
313
试验地点
2
主要终点
Pediatric chemotherapy-induced peripheral neuropathy (P-CIN) scale

研究概览

简要总结

The goal of this study was to conduct a cross-cultural adaptation of the P-CIN into the Chinese context, assess its psychometric properties, and determine the cut-off value of CIPN among Chinese pediatric oncology patients.

Participants provided demographic and clinical characteristics, and complete the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.

详细描述

A methodological, descriptive study was conducted.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • (1) 6 to 18 years of age
  • (2) were diagnosed with cancer
  • (3) had received or were currently receiving neurotoxic chemotherapy drugs (e.g., Vincristine, Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Ixabepilone, Bortezomib, Thalidomide)
  • (4) were able to communicate, read, and write in Chinese without significant hearing and vision problems to ensure they understood the P-CIN.

排除标准

  • (1) had a diagnosis of cancer in the central nervous system (CNS) cancer, cancer relapse or secondary cancer
  • (2) in the terminal stage
  • (3) planned to receive multiple cancer treatment (e.g., radiotherapy and immunotherapy)
  • (4) suffered from other neuromuscular diseases (e.g., traumatic brain injury and cerebral palsy)
  • (5) had a developmental deficit (e.g., Down's syndrome and other chromosomal disorders)
  • (6) have suffered from psychiatric diseases or used antipsychotic drugs
  • (7) had peripheral neuropathy symptoms caused by diabetes, genetic diseases, spinal cord injury, or alcoholism, or
  • (8) had other neuromuscular disorders (e.g., traumatic brain injury, cerebral palsy).

结局指标

主要结局

Pediatric chemotherapy-induced peripheral neuropathy (P-CIN) scale

时间窗: Baseline

For measuring participants' peripheral neuropathy induced by chemotherapy. The total score ranges from 0 to 65 with higher scores indicating more severe chemotherpay induced peripheral neuropathy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Eva Ho

Associate professor

The Hong Kong Polytechnic University

研究点 (2)

Loading locations...

相似试验

Cross-cultural Adaptation and Validation of the... | 临床试验